| 0 |
GROWING TERATOMA SYNDROME |
32 |
0.9697 |
| 1 |
LYMPHOID TISSUE HYPOPLASIA |
148 |
0.9673 |
| 2 |
THYMUS HYPOPLASIA |
152 |
0.8736 |
| 3 |
HUMAN BOCAVIRUS INFECTION |
133 |
0.7037 |
| 4 |
HAEMATOPOIETIC STEM CELL MOBILISATION |
31 |
0.4844 |
| 5 |
OVARIAN GERM CELL TERATOMA |
37 |
0.4625 |
| 6 |
CHORIOCARCINOMA |
32 |
0.4051 |
| 7 |
BASAL GANGLION DEGENERATION |
35 |
0.3723 |
| 8 |
MEDULLOBLASTOMA RECURRENT |
40 |
0.3540 |
| 9 |
RENAL SALT-WASTING SYNDROME |
136 |
0.3469 |
| 10 |
NEPHROBLASTOMA |
42 |
0.3307 |
| 11 |
CYSTITIS BACTERIAL |
110 |
0.3254 |
| 12 |
MALIGNANT TRANSFORMATION |
137 |
0.3051 |
| 13 |
NOROVIRUS TEST POSITIVE |
97 |
0.2985 |
| 14 |
NEUROBLASTOMA RECURRENT |
58 |
0.2857 |
| 15 |
TERATOMA |
57 |
0.2651 |
| 16 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
251 |
0.2650 |
| 17 |
MYCOBACTERIUM CHELONAE INFECTION |
184 |
0.2490 |
| 18 |
DISSEMINATED ASPERGILLOSIS |
114 |
0.2415 |
| 19 |
HIGH-GRADE B-CELL LYMPHOMA |
45 |
0.2406 |
| 20 |
MEDULLOBLASTOMA |
35 |
0.2349 |
| 21 |
REFRACTORY CANCER |
48 |
0.2254 |
| 22 |
MENINGITIS TUBERCULOUS |
125 |
0.2236 |
| 23 |
TREATMENT RELATED SECONDARY MALIGNANCY |
45 |
0.2217 |
| 24 |
OVARIAN FAILURE |
117 |
0.2187 |
| 25 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
482 |
0.2184 |
| 26 |
PRIMARY HYPOGONADISM |
34 |
0.2166 |
| 27 |
SECONDARY IMMUNODEFICIENCY |
261 |
0.2148 |
| 28 |
BLOOD STEM CELL TRANSPLANT FAILURE |
45 |
0.2093 |
| 29 |
ABSCESS BACTERIAL |
73 |
0.2011 |
| 30 |
OSTEOSARCOMA |
74 |
0.1922 |
| 31 |
NEUROBLASTOMA |
73 |
0.1906 |
| 32 |
SWEAT GLAND TUMOUR |
44 |
0.1872 |
| 33 |
T-CELL TYPE ACUTE LEUKAEMIA |
38 |
0.1863 |
| 34 |
CAECITIS |
78 |
0.1733 |
| 35 |
B-CELL LYMPHOMA RECURRENT |
94 |
0.1731 |
| 36 |
HEPATOSPLENIC T-CELL LYMPHOMA |
64 |
0.1725 |
| 37 |
CORONA VIRUS INFECTION |
71 |
0.1651 |
| 38 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
38 |
0.1638 |
| 39 |
ENGRAFTMENT SYNDROME |
90 |
0.1523 |
| 40 |
CONGENITAL APLASIA |
45 |
0.1447 |
| 41 |
NEUTROPENIC INFECTION |
136 |
0.1421 |
| 42 |
PSEUDOMONAL SEPSIS |
245 |
0.1398 |
| 43 |
CENTRAL HYPOTHYROIDISM |
46 |
0.1390 |
| 44 |
MANTLE CELL LYMPHOMA RECURRENT |
59 |
0.1356 |
| 45 |
HUMAN HERPESVIRUS 6 INFECTION |
244 |
0.1290 |
| 46 |
VENOOCCLUSIVE LIVER DISEASE |
636 |
0.1287 |
| 47 |
NEUTROPENIC COLITIS |
263 |
0.1271 |
| 48 |
TISSUE INFILTRATION |
37 |
0.1254 |
| 49 |
ACUTE MYELOMONOCYTIC LEUKAEMIA |
31 |
0.1225 |
| 50 |
REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS |
37 |
0.1182 |
| 51 |
PARAINFLUENZAE VIRUS INFECTION |
180 |
0.1182 |
| 52 |
FEBRILE NEUTROPENIA |
7745 |
0.1166 |
| 53 |
VENOOCCLUSIVE DISEASE |
286 |
0.1141 |
| 54 |
APLASIA |
222 |
0.1133 |
| 55 |
ENTEROBACTER INFECTION |
190 |
0.1130 |
| 56 |
CYTOMEGALOVIRUS CHORIORETINITIS |
220 |
0.1127 |
| 57 |
CHLOROMA |
47 |
0.1114 |
| 58 |
ASPERGILLUS INFECTION |
725 |
0.1104 |
| 59 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
36 |
0.1098 |
| 60 |
MYELOID LEUKAEMIA |
54 |
0.1078 |
| 61 |
NEUTROPENIC SEPSIS |
733 |
0.1025 |
| 62 |
VIRAEMIA |
141 |
0.1017 |
| 63 |
PLASMA CELL LEUKAEMIA |
61 |
0.1017 |
| 64 |
OTOTOXICITY |
185 |
0.0999 |
| 65 |
STEM CELL TRANSPLANT |
248 |
0.0992 |
| 66 |
KLEBSIELLA SEPSIS |
111 |
0.0985 |
| 67 |
VIRAL HAEMORRHAGIC CYSTITIS |
70 |
0.0983 |
| 68 |
COMPLICATIONS OF BONE MARROW TRANSPLANT |
35 |
0.0970 |
| 69 |
KLEBSIELLA BACTERAEMIA |
91 |
0.0958 |
| 70 |
HAEMATOTOXICITY |
894 |
0.0940 |
| 71 |
AZOOSPERMIA |
36 |
0.0938 |
| 72 |
PSEUDOMONAL BACTERAEMIA |
80 |
0.0937 |
| 73 |
ACUTE MYELOID LEUKAEMIA |
1451 |
0.0930 |
| 74 |
PLASMABLASTIC LYMPHOMA |
33 |
0.0922 |
| 75 |
RADIATION OESOPHAGITIS |
35 |
0.0919 |
| 76 |
FOLLICULAR LYMPHOMA |
80 |
0.0909 |
| 77 |
DIFFUSE ALVEOLAR DAMAGE |
104 |
0.0904 |
| 78 |
MUCOSAL INFLAMMATION |
2346 |
0.0895 |
| 79 |
LYMPHOMA TRANSFORMATION |
32 |
0.0889 |
| 80 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
91 |
0.0885 |
| 81 |
TUMOUR LYSIS SYNDROME |
776 |
0.0881 |
| 82 |
SMALL CELL LUNG CANCER |
133 |
0.0880 |
| 83 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
115 |
0.0873 |
| 84 |
FEBRILE BONE MARROW APLASIA |
370 |
0.0870 |
| 85 |
MYELODYSPLASTIC SYNDROME |
1203 |
0.0831 |
| 86 |
MINIMAL RESIDUAL DISEASE |
40 |
0.0828 |
| 87 |
TRICHOSPORON INFECTION |
33 |
0.0815 |
| 88 |
SUPERIOR VENA CAVA SYNDROME |
49 |
0.0811 |
| 89 |
GRAFT VERSUS HOST DISEASE IN LIVER |
58 |
0.0810 |
| 90 |
CYSTITIS VIRAL |
31 |
0.0809 |
| 91 |
ENTEROCOCCAL BACTERAEMIA |
85 |
0.0802 |
| 92 |
ENCEPHALITIS CYTOMEGALOVIRUS |
35 |
0.0799 |
| 93 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
31 |
0.0797 |
| 94 |
CYTOPENIA |
976 |
0.0796 |
| 95 |
FUSARIUM INFECTION |
54 |
0.0771 |
| 96 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
576 |
0.0767 |
| 97 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
45 |
0.0759 |
| 98 |
GASTROINTESTINAL FUNGAL INFECTION |
39 |
0.0757 |
| 99 |
ANGIOCENTRIC LYMPHOMA |
37 |
0.0752 |
| 100 |
SKIN CANDIDA |
39 |
0.0747 |
| 101 |
SECOND PRIMARY MALIGNANCY |
620 |
0.0745 |
| 102 |
PLASMA CELL MYELOMA REFRACTORY |
99 |
0.0740 |
| 103 |
CYTOGENETIC ABNORMALITY |
83 |
0.0735 |
| 104 |
DIFFUSE LARGE B-CELL LYMPHOMA |
560 |
0.0726 |
| 105 |
PULMONARY VASCULAR DISORDER |
34 |
0.0722 |
| 106 |
HYPERFERRITINAEMIA |
31 |
0.0719 |
| 107 |
SYSTEMIC MYCOSIS |
84 |
0.0719 |
| 108 |
CYSTITIS HAEMORRHAGIC |
287 |
0.0711 |
| 109 |
BRONCHOPULMONARY ASPERGILLOSIS |
542 |
0.0698 |
| 110 |
HISTIOCYTOSIS HAEMATOPHAGIC |
207 |
0.0697 |
| 111 |
CYTOMEGALOVIRUS VIRAEMIA |
309 |
0.0694 |
| 112 |
PERIPHERAL MOTOR NEUROPATHY |
97 |
0.0692 |
| 113 |
JC VIRUS INFECTION |
109 |
0.0681 |
| 114 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
63 |
0.0681 |
| 115 |
HEPATITIS B REACTIVATION |
215 |
0.0677 |
| 116 |
BK VIRUS INFECTION |
228 |
0.0675 |
| 117 |
BONE MARROW TOXICITY |
80 |
0.0675 |
| 118 |
PNEUMATOSIS INTESTINALIS |
191 |
0.0669 |
| 119 |
BONE MARROW FAILURE |
1345 |
0.0661 |
| 120 |
STREPTOCOCCAL BACTERAEMIA |
71 |
0.0653 |
| 121 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
134 |
0.0624 |
| 122 |
ADENOVIRUS INFECTION |
179 |
0.0617 |
| 123 |
NEOPLASM RECURRENCE |
208 |
0.0613 |
| 124 |
ABDOMINAL COMPARTMENT SYNDROME |
39 |
0.0612 |
| 125 |
FUNGAEMIA |
96 |
0.0610 |
| 126 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
167 |
0.0604 |
| 127 |
ACUTE GRAFT VERSUS HOST DISEASE |
274 |
0.0598 |
| 128 |
ESCHERICHIA BACTERAEMIA |
140 |
0.0595 |
| 129 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
81 |
0.0587 |
| 130 |
CLOSTRIDIUM DIFFICILE COLITIS |
623 |
0.0587 |
| 131 |
MYELOSUPPRESSION |
2115 |
0.0587 |
| 132 |
ASPERGILLOSIS |
75 |
0.0574 |
| 133 |
CERVIX DISORDER |
41 |
0.0569 |
| 134 |
LEUKAEMIA RECURRENT |
95 |
0.0561 |
| 135 |
STENOTROPHOMONAS INFECTION |
76 |
0.0560 |
| 136 |
ENTEROCOCCAL SEPSIS |
45 |
0.0556 |
| 137 |
BACTERIAL SEPSIS |
181 |
0.0555 |
| 138 |
FUNGAL SEPSIS |
46 |
0.0554 |
| 139 |
THERAPY PARTIAL RESPONDER |
861 |
0.0551 |
| 140 |
PNEUMONIA KLEBSIELLA |
101 |
0.0549 |
| 141 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
242 |
0.0547 |
| 142 |
CLOSTRIDIUM COLITIS |
66 |
0.0544 |
| 143 |
ACUTE GRAFT VERSUS HOST DISEASE IN LIVER |
39 |
0.0542 |
| 144 |
VENA CAVA THROMBOSIS |
89 |
0.0535 |
| 145 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
119 |
0.0534 |
| 146 |
ENTEROCOCCAL INFECTION |
257 |
0.0531 |
| 147 |
GRAFT VERSUS HOST DISEASE IN SKIN |
117 |
0.0531 |
| 148 |
SYSTEMIC CANDIDA |
133 |
0.0529 |
| 149 |
KLEBSIELLA INFECTION |
262 |
0.0518 |
| 150 |
PULMONARY VENO-OCCLUSIVE DISEASE |
36 |
0.0514 |
| 151 |
STAPHYLOCOCCAL BACTERAEMIA |
223 |
0.0513 |
| 152 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
108 |
0.0507 |
| 153 |
NEUROENDOCRINE CARCINOMA |
35 |
0.0506 |
| 154 |
TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA |
33 |
0.0503 |
| 155 |
PANCYTOPENIA |
2784 |
0.0498 |
| 156 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
141 |
0.0498 |
| 157 |
FANCONI SYNDROME |
70 |
0.0495 |
| 158 |
CARDIOTOXICITY |
439 |
0.0492 |
| 159 |
MUCORMYCOSIS |
127 |
0.0488 |
| 160 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
41 |
0.0486 |
| 161 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
68 |
0.0481 |
| 162 |
GASTROINTESTINAL TOXICITY |
231 |
0.0480 |
| 163 |
PREMATURE MENOPAUSE |
44 |
0.0476 |
| 164 |
PULMONARY MYCOSIS |
37 |
0.0475 |
| 165 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
452 |
0.0473 |
| 166 |
T-CELL LYMPHOMA |
54 |
0.0471 |
| 167 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
83 |
0.0469 |
| 168 |
CANDIDA SEPSIS |
42 |
0.0468 |
| 169 |
RHINOVIRUS INFECTION |
182 |
0.0467 |
| 170 |
UTERINE ENLARGEMENT |
36 |
0.0453 |
| 171 |
PERIPHERAL SENSORY NEUROPATHY |
263 |
0.0449 |
| 172 |
BACTERAEMIA |
533 |
0.0449 |
| 173 |
PERIPHERAL SENSORIMOTOR NEUROPATHY |
56 |
0.0446 |
| 174 |
GASTROENTERITIS NOROVIRUS |
59 |
0.0444 |
| 175 |
CHRONIC GRAFT VERSUS HOST DISEASE |
160 |
0.0443 |
| 176 |
OESOPHAGEAL CANDIDIASIS |
176 |
0.0441 |
| 177 |
AORTIC THROMBOSIS |
51 |
0.0441 |
| 178 |
GENE MUTATION |
87 |
0.0439 |
| 179 |
ESCHERICHIA SEPSIS |
127 |
0.0438 |
| 180 |
HYPOGAMMAGLOBULINAEMIA |
285 |
0.0433 |
| 181 |
EPSTEIN-BARR VIRAEMIA |
48 |
0.0433 |
| 182 |
GRAFT VERSUS HOST DISEASE |
311 |
0.0432 |
| 183 |
CEREBRAL TOXOPLASMOSIS |
39 |
0.0418 |
| 184 |
TUMOUR NECROSIS |
44 |
0.0416 |
| 185 |
RENAL TUBULAR DISORDER |
116 |
0.0412 |
| 186 |
METASTASES TO ADRENALS |
38 |
0.0412 |
| 187 |
PNEUMONIA CYTOMEGALOVIRAL |
80 |
0.0412 |
| 188 |
EPSTEIN-BARR VIRUS INFECTION |
256 |
0.0409 |
| 189 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
105 |
0.0407 |
| 190 |
STREPTOCOCCAL SEPSIS |
48 |
0.0405 |
| 191 |
ENCEPHALITIS VIRAL |
49 |
0.0402 |
| 192 |
ENTERITIS |
255 |
0.0398 |
| 193 |
RADIATION PNEUMONITIS |
85 |
0.0397 |
| 194 |
CAPILLARY LEAK SYNDROME |
82 |
0.0396 |
| 195 |
VARICELLA ZOSTER VIRUS INFECTION |
82 |
0.0395 |
| 196 |
PNEUMONIA FUNGAL |
156 |
0.0395 |
| 197 |
PULMONARY TOXICITY |
276 |
0.0390 |
| 198 |
HEPATOSPLENOMEGALY |
99 |
0.0385 |
| 199 |
RECALL PHENOMENON |
32 |
0.0383 |
| 200 |
DISEASE PROGRESSION |
4531 |
0.0383 |
| 201 |
FEBRILE INFECTION |
45 |
0.0382 |
| 202 |
NEPHROPATHY TOXIC |
426 |
0.0379 |
| 203 |
BLOOD CULTURE POSITIVE |
113 |
0.0377 |
| 204 |
NEUTROPENIA |
5067 |
0.0372 |
| 205 |
THROMBOTIC MICROANGIOPATHY |
363 |
0.0372 |
| 206 |
OESOPHAGEAL PERFORATION |
31 |
0.0372 |
| 207 |
THROMBOCYTOPENIA |
4139 |
0.0370 |
| 208 |
VENOUS THROMBOSIS |
145 |
0.0369 |
| 209 |
CONTINUOUS HAEMODIAFILTRATION |
36 |
0.0368 |
| 210 |
NEUROLOGICAL DECOMPENSATION |
85 |
0.0367 |
| 211 |
GRANULOCYTE COUNT DECREASED |
68 |
0.0366 |
| 212 |
SEPTIC SHOCK |
1593 |
0.0366 |
| 213 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
186 |
0.0365 |
| 214 |
MANTLE CELL LYMPHOMA |
55 |
0.0361 |
| 215 |
BACTERIAL INFECTION |
669 |
0.0358 |
| 216 |
APLASTIC ANAEMIA |
187 |
0.0358 |
| 217 |
LYMPHOPENIA |
496 |
0.0350 |
| 218 |
PHARYNGEAL INFLAMMATION |
42 |
0.0345 |
| 219 |
DRUG CLEARANCE DECREASED |
45 |
0.0344 |
| 220 |
ACQUIRED GENE MUTATION |
45 |
0.0343 |
| 221 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
972 |
0.0343 |
| 222 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
279 |
0.0338 |
| 223 |
BONE MARROW DISORDER |
101 |
0.0334 |
| 224 |
METASTASES TO MENINGES |
76 |
0.0334 |
| 225 |
MYELOPATHY |
63 |
0.0331 |
| 226 |
CYTOMEGALOVIRUS INFECTION |
547 |
0.0329 |
| 227 |
CYTOKINE RELEASE SYNDROME |
658 |
0.0328 |
| 228 |
PLASMACYTOMA |
61 |
0.0327 |
| 229 |
ENCEPHALITIS AUTOIMMUNE |
43 |
0.0327 |
| 230 |
HYPOFIBRINOGENAEMIA |
32 |
0.0323 |
| 231 |
BONE MARROW DEPRESSION |
31 |
0.0318 |
| 232 |
HEPATITIS E |
50 |
0.0316 |
| 233 |
CATHETER RELATED INFECTION |
32 |
0.0316 |
| 234 |
BLOOD FIBRINOGEN DECREASED |
36 |
0.0315 |
| 235 |
LEUKOENCEPHALOPATHY |
116 |
0.0311 |
| 236 |
SKIN TOXICITY |
174 |
0.0308 |
| 237 |
NEUTROPHIL COUNT ABNORMAL |
87 |
0.0308 |
| 238 |
NEUROTOXICITY |
537 |
0.0306 |
| 239 |
HYPOCHROMIC ANAEMIA |
31 |
0.0306 |
| 240 |
ENTEROCOLITIS |
176 |
0.0305 |
| 241 |
PULMONARY HAEMORRHAGE |
238 |
0.0304 |
| 242 |
PNEUMONIA PSEUDOMONAL |
46 |
0.0300 |
| 243 |
INFECTION REACTIVATION |
34 |
0.0297 |
| 244 |
STRONGYLOIDIASIS |
48 |
0.0297 |
| 245 |
STAPHYLOCOCCAL SEPSIS |
145 |
0.0293 |
| 246 |
NEUTROPHIL COUNT DECREASED |
1191 |
0.0292 |
| 247 |
DYSPLASIA |
35 |
0.0292 |
| 248 |
PARAPARESIS |
52 |
0.0292 |
| 249 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
461 |
0.0291 |
| 250 |
BICYTOPENIA |
57 |
0.0291 |
| 251 |
NON-HODGKIN'S LYMPHOMA |
38 |
0.0290 |
| 252 |
NEOPLASM PROGRESSION |
971 |
0.0279 |
| 253 |
HEPATITIS B |
168 |
0.0279 |
| 254 |
PSEUDOMONAS INFECTION |
236 |
0.0275 |
| 255 |
PLASMA CELL MYELOMA RECURRENT |
89 |
0.0274 |
| 256 |
B-CELL LYMPHOMA |
93 |
0.0274 |
| 257 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
162 |
0.0273 |
| 258 |
METASTASIS |
195 |
0.0273 |
| 259 |
PLATELET TRANSFUSION |
35 |
0.0272 |
| 260 |
SUBILEUS |
56 |
0.0269 |
| 261 |
SEPSIS |
2998 |
0.0269 |
| 262 |
PNEUMOCYSTIS JIROVECII INFECTION |
32 |
0.0268 |
| 263 |
ESCHERICHIA TEST POSITIVE |
32 |
0.0267 |
| 264 |
HERPES SIMPLEX |
172 |
0.0264 |
| 265 |
LEUKOPENIA |
1300 |
0.0260 |
| 266 |
MENINGITIS BACTERIAL |
37 |
0.0258 |
| 267 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
454 |
0.0256 |
| 268 |
CUTANEOUS T-CELL LYMPHOMA |
32 |
0.0254 |
| 269 |
ENCEPHALOPATHY |
618 |
0.0251 |
| 270 |
LUNG CONSOLIDATION |
70 |
0.0250 |
| 271 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
251 |
0.0250 |
| 272 |
CLOSTRIDIAL INFECTION |
84 |
0.0248 |
| 273 |
QUADRIPARESIS |
41 |
0.0247 |
| 274 |
DEAFNESS NEUROSENSORY |
81 |
0.0246 |
| 275 |
HYPOALBUMINAEMIA |
191 |
0.0245 |
| 276 |
DISSEMINATED INTRAVASCULAR COAGULATION |
341 |
0.0242 |
| 277 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
311 |
0.0241 |
| 278 |
OESOPHAGITIS |
256 |
0.0234 |
| 279 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
62 |
0.0233 |
| 280 |
TRAUMATIC LUNG INJURY |
45 |
0.0233 |
| 281 |
PNEUMOMEDIASTINUM |
42 |
0.0232 |
| 282 |
AGRANULOCYTOSIS |
428 |
0.0230 |
| 283 |
NOROVIRUS INFECTION |
33 |
0.0229 |
| 284 |
ENCEPHALITIS |
158 |
0.0228 |
| 285 |
ARTERIAL THROMBOSIS |
44 |
0.0227 |
| 286 |
CANDIDA INFECTION |
384 |
0.0227 |
| 287 |
MYELITIS |
35 |
0.0226 |
| 288 |
RECURRENT CANCER |
92 |
0.0225 |
| 289 |
LEFT VENTRICULAR DYSFUNCTION |
151 |
0.0225 |
| 290 |
JUGULAR VEIN THROMBOSIS |
40 |
0.0225 |
| 291 |
PULMONARY ALVEOLAR HAEMORRHAGE |
126 |
0.0224 |
| 292 |
DEVICE RELATED SEPSIS |
45 |
0.0223 |
| 293 |
PNEUMONITIS |
606 |
0.0222 |
| 294 |
IMMUNE-MEDIATED ENTEROCOLITIS |
81 |
0.0220 |
| 295 |
METASTASES TO PERITONEUM |
55 |
0.0218 |
| 296 |
MENINGITIS CRYPTOCOCCAL |
38 |
0.0217 |
| 297 |
ACUTE LEUKAEMIA |
35 |
0.0217 |
| 298 |
HYPOPHOSPHATAEMIA |
158 |
0.0214 |
| 299 |
CYTOMEGALOVIRUS COLITIS |
49 |
0.0213 |
| 300 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
73 |
0.0213 |
| 301 |
HYPERTRANSAMINASAEMIA |
147 |
0.0211 |
| 302 |
SYSTEMIC INFECTION |
35 |
0.0211 |
| 303 |
BONE MARROW TRANSPLANT |
40 |
0.0211 |
| 304 |
LYMPHOMA |
326 |
0.0211 |
| 305 |
SERUM FERRITIN INCREASED |
111 |
0.0210 |
| 306 |
ESCHERICHIA INFECTION |
173 |
0.0210 |
| 307 |
LUNG INFILTRATION |
185 |
0.0209 |
| 308 |
GASTROINTESTINAL NECROSIS |
61 |
0.0209 |
| 309 |
HYPOMAGNESAEMIA |
291 |
0.0209 |
| 310 |
SOFT TISSUE INFECTION |
38 |
0.0207 |
| 311 |
GASTRITIS HAEMORRHAGIC |
31 |
0.0207 |
| 312 |
POLYNEUROPATHY |
246 |
0.0205 |
| 313 |
FANCONI SYNDROME ACQUIRED |
36 |
0.0205 |
| 314 |
METASTASES TO LYMPH NODES |
138 |
0.0204 |
| 315 |
INFECTIOUS PLEURAL EFFUSION |
31 |
0.0204 |
| 316 |
HYPERBILIRUBINAEMIA |
208 |
0.0201 |
| 317 |
OSTEOLYSIS |
41 |
0.0200 |
| 318 |
DRUG RESISTANCE |
508 |
0.0198 |
| 319 |
OPTIC ATROPHY |
32 |
0.0196 |
| 320 |
CYTOMEGALOVIRUS TEST POSITIVE |
35 |
0.0196 |
| 321 |
HEPATOTOXICITY |
433 |
0.0194 |
| 322 |
QUADRIPLEGIA |
40 |
0.0194 |
| 323 |
MALIGNANT NEOPLASM PROGRESSION |
1988 |
0.0194 |
| 324 |
INTRACARDIAC THROMBUS |
59 |
0.0192 |
| 325 |
DIABETES INSIPIDUS |
46 |
0.0191 |
| 326 |
METASTASES TO LUNG |
220 |
0.0190 |
| 327 |
PAPILLARY THYROID CANCER |
33 |
0.0190 |
| 328 |
LOBAR PNEUMONIA |
35 |
0.0189 |
| 329 |
LYMPHADENOPATHY MEDIASTINAL |
36 |
0.0188 |
| 330 |
TOXIC ENCEPHALOPATHY |
95 |
0.0187 |
| 331 |
SMALL INTESTINAL PERFORATION |
35 |
0.0186 |
| 332 |
STREPTOCOCCAL INFECTION |
103 |
0.0185 |
| 333 |
GROWTH RETARDATION |
54 |
0.0183 |
| 334 |
RESPIRATORY FAILURE |
1314 |
0.0180 |
| 335 |
TUMOUR HAEMORRHAGE |
51 |
0.0179 |
| 336 |
DRUG TOXICITY |
242 |
0.0177 |
| 337 |
HYPERURICAEMIA |
73 |
0.0177 |
| 338 |
DISEASE RECURRENCE |
840 |
0.0176 |
| 339 |
MULTI-ORGAN FAILURE |
305 |
0.0176 |
| 340 |
LUNG ABSCESS |
37 |
0.0176 |
| 341 |
ANAEMIA |
3353 |
0.0176 |
| 342 |
TRANSPLANT FAILURE |
43 |
0.0175 |
| 343 |
HYPOPROTEINAEMIA |
33 |
0.0174 |
| 344 |
CORONARY ARTERY THROMBOSIS |
35 |
0.0173 |
| 345 |
HYPERPHOSPHATAEMIA |
37 |
0.0172 |
| 346 |
ELECTROLYTE IMBALANCE |
199 |
0.0171 |
| 347 |
CARDIOMYOPATHY |
253 |
0.0171 |
| 348 |
CEREBRAL VENOUS THROMBOSIS |
31 |
0.0171 |
| 349 |
COLITIS |
646 |
0.0170 |
| 350 |
IMMUNE-MEDIATED LUNG DISEASE |
31 |
0.0170 |
| 351 |
FUNGAL INFECTION |
559 |
0.0168 |
| 352 |
IMMUNE-MEDIATED HEPATITIS |
34 |
0.0166 |
| 353 |
HAEMODYNAMIC INSTABILITY |
126 |
0.0165 |
| 354 |
EJECTION FRACTION DECREASED |
257 |
0.0165 |
| 355 |
HYDROCEPHALUS |
90 |
0.0165 |
| 356 |
EMBOLISM VENOUS |
50 |
0.0165 |
| 357 |
ODYNOPHAGIA |
97 |
0.0162 |
| 358 |
HYPOKALAEMIA |
746 |
0.0161 |
| 359 |
FOETAL GROWTH RESTRICTION |
98 |
0.0161 |
| 360 |
BRAIN HERNIATION |
48 |
0.0161 |
| 361 |
GRANULOCYTOPENIA |
91 |
0.0160 |
| 362 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
164 |
0.0160 |
| 363 |
HYPOPHYSITIS |
32 |
0.0159 |
| 364 |
URINARY TRACT INFECTION BACTERIAL |
40 |
0.0158 |
| 365 |
CANDIDIASIS |
63 |
0.0157 |
| 366 |
LYMPHOPROLIFERATIVE DISORDER |
46 |
0.0156 |
| 367 |
EMBOLISM |
130 |
0.0156 |
| 368 |
GASTROINTESTINAL INFLAMMATION |
122 |
0.0156 |
| 369 |
CARDIAC TAMPONADE |
74 |
0.0156 |
| 370 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
106 |
0.0155 |
| 371 |
GUILLAIN-BARRE SYNDROME |
75 |
0.0155 |
| 372 |
PLATELET DISORDER |
39 |
0.0155 |
| 373 |
HYPERNATRAEMIA |
77 |
0.0154 |
| 374 |
PLASMA CELL MYELOMA |
601 |
0.0154 |
| 375 |
HYPERTRIGLYCERIDAEMIA |
90 |
0.0154 |
| 376 |
DYSAESTHESIA |
47 |
0.0153 |
| 377 |
ADRENAL INSUFFICIENCY |
186 |
0.0153 |
| 378 |
ILEUS |
190 |
0.0153 |
| 379 |
CLOSTRIDIUM TEST POSITIVE |
33 |
0.0150 |
| 380 |
FIBROSIS |
46 |
0.0149 |
| 381 |
VENTRICULAR HYPOKINESIA |
48 |
0.0149 |
| 382 |
MULTIPLE-DRUG RESISTANCE |
46 |
0.0148 |
| 383 |
COVID-19 PNEUMONIA |
175 |
0.0148 |
| 384 |
THERAPY NON-RESPONDER |
663 |
0.0147 |
| 385 |
VENTRICULAR DYSFUNCTION |
38 |
0.0146 |
| 386 |
RETINAL HAEMORRHAGE |
104 |
0.0146 |
| 387 |
WHITE BLOOD CELL DISORDER |
39 |
0.0146 |
| 388 |
DEVICE RELATED INFECTION |
224 |
0.0145 |
| 389 |
LYMPHADENOPATHY |
513 |
0.0145 |
| 390 |
INFECTION |
2053 |
0.0142 |
| 391 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
123 |
0.0141 |
| 392 |
VASCULAR DEVICE INFECTION |
64 |
0.0141 |
| 393 |
NOCARDIOSIS |
36 |
0.0141 |
| 394 |
PNEUMONIA BACTERIAL |
129 |
0.0140 |
| 395 |
METASTASES TO LIVER |
246 |
0.0140 |
| 396 |
HYPERPYREXIA |
59 |
0.0139 |
| 397 |
STOMATITIS |
844 |
0.0139 |
| 398 |
PNEUMONIA VIRAL |
44 |
0.0138 |
| 399 |
CARDIAC DYSFUNCTION |
51 |
0.0137 |
| 400 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
52 |
0.0136 |
| 401 |
HYPOVOLAEMIC SHOCK |
65 |
0.0136 |
| 402 |
PNEUMOTHORAX |
215 |
0.0135 |
| 403 |
SUBDURAL HAEMORRHAGE |
37 |
0.0135 |
| 404 |
AREFLEXIA |
36 |
0.0135 |
| 405 |
METASTATIC NEOPLASM |
58 |
0.0134 |
| 406 |
THROMBOPHLEBITIS |
47 |
0.0134 |
| 407 |
SPLENOMEGALY |
157 |
0.0134 |
| 408 |
ACUTE HEPATIC FAILURE |
183 |
0.0134 |
| 409 |
HYPOCALCAEMIA |
253 |
0.0134 |
| 410 |
ATELECTASIS |
129 |
0.0133 |
| 411 |
CHRONIC SINUSITIS |
50 |
0.0133 |
| 412 |
AMYLASE INCREASED |
49 |
0.0133 |
| 413 |
PLATELET COUNT DECREASED |
1413 |
0.0132 |
| 414 |
ILEUS PARALYTIC |
59 |
0.0132 |
| 415 |
MENINGITIS ASEPTIC |
59 |
0.0131 |
| 416 |
VITREOUS HAEMORRHAGE |
36 |
0.0130 |
| 417 |
CHRONIC MYELOID LEUKAEMIA |
60 |
0.0130 |
| 418 |
LYMPHOCYTE COUNT DECREASED |
229 |
0.0129 |
| 419 |
ORGANISING PNEUMONIA |
64 |
0.0129 |
| 420 |
HAEMOGLOBIN ABNORMAL |
83 |
0.0129 |
| 421 |
SUSPECTED OFF LABEL USE |
58 |
0.0128 |
| 422 |
HEPATITIS FULMINANT |
38 |
0.0128 |
| 423 |
IMMUNOSUPPRESSION |
112 |
0.0127 |
| 424 |
DERMATOMYOSITIS |
32 |
0.0126 |
| 425 |
RETINOPATHY |
47 |
0.0126 |
| 426 |
STAPHYLOCOCCAL INFECTION |
415 |
0.0126 |
| 427 |
NEOPLASM |
144 |
0.0125 |
| 428 |
METASTASES TO SPINE |
42 |
0.0125 |
| 429 |
HYPOTHYROIDISM |
399 |
0.0125 |
| 430 |
HEPATIC LESION |
54 |
0.0125 |
| 431 |
CONGESTIVE CARDIOMYOPATHY |
52 |
0.0125 |
| 432 |
LUNG NEOPLASM |
53 |
0.0124 |
| 433 |
EXTRAVASATION |
51 |
0.0124 |
| 434 |
HYPOXIA |
435 |
0.0123 |
| 435 |
BLOOD BILIRUBIN INCREASED |
333 |
0.0123 |
| 436 |
ABDOMINAL MASS |
33 |
0.0123 |
| 437 |
ACUTE RESPIRATORY FAILURE |
236 |
0.0123 |
| 438 |
NEUROPATHY PERIPHERAL |
1165 |
0.0122 |
| 439 |
HEPATIC NECROSIS |
46 |
0.0122 |
| 440 |
PERICARDIAL EFFUSION |
282 |
0.0122 |
| 441 |
RESPIRATORY DISTRESS |
336 |
0.0122 |
| 442 |
CLOSTRIDIUM DIFFICILE INFECTION |
265 |
0.0121 |
| 443 |
PARAPLEGIA |
35 |
0.0121 |
| 444 |
INTESTINAL PERFORATION |
136 |
0.0121 |
| 445 |
PLATELET COUNT ABNORMAL |
73 |
0.0121 |
| 446 |
CARDIOPULMONARY FAILURE |
47 |
0.0120 |
| 447 |
CACHEXIA |
62 |
0.0120 |
| 448 |
PRODUCT USE IN UNAPPROVED INDICATION |
2973 |
0.0120 |
| 449 |
PAPILLOEDEMA |
54 |
0.0119 |
| 450 |
HYPERCAPNIA |
36 |
0.0119 |
| 451 |
WHITE BLOOD CELL COUNT ABNORMAL |
76 |
0.0119 |
| 452 |
HEPATIC FAILURE |
359 |
0.0119 |
| 453 |
HYDRONEPHROSIS |
89 |
0.0119 |
| 454 |
LEUKAEMIA |
112 |
0.0119 |
| 455 |
VIRAL INFECTION |
394 |
0.0118 |
| 456 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
649 |
0.0118 |
| 457 |
DERMATITIS EXFOLIATIVE GENERALISED |
41 |
0.0118 |
| 458 |
HAEMODIALYSIS |
99 |
0.0118 |
| 459 |
ASCITES |
346 |
0.0118 |
| 460 |
LUNG OPACITY |
31 |
0.0118 |
| 461 |
WHITE BLOOD CELL COUNT DECREASED |
1255 |
0.0116 |
| 462 |
LARGE INTESTINE PERFORATION |
80 |
0.0115 |
| 463 |
MONOPLEGIA |
50 |
0.0115 |
| 464 |
BONE LESION |
41 |
0.0114 |
| 465 |
IMMUNE THROMBOCYTOPENIA |
52 |
0.0113 |
| 466 |
PLEURAL EFFUSION |
687 |
0.0113 |
| 467 |
ABDOMINAL TENDERNESS |
56 |
0.0113 |
| 468 |
ACUTE PULMONARY OEDEMA |
63 |
0.0112 |
| 469 |
HEPATOMEGALY |
110 |
0.0112 |
| 470 |
STRESS CARDIOMYOPATHY |
65 |
0.0112 |
| 471 |
MALNUTRITION |
125 |
0.0112 |
| 472 |
HERPES VIRUS INFECTION |
64 |
0.0111 |
| 473 |
GASTROINTESTINAL PERFORATION |
46 |
0.0111 |
| 474 |
MYOSITIS |
99 |
0.0110 |
| 475 |
OLIGURIA |
68 |
0.0109 |
| 476 |
SHOCK HAEMORRHAGIC |
89 |
0.0109 |
| 477 |
METABOLIC DISORDER |
63 |
0.0108 |
| 478 |
ESCHERICHIA URINARY TRACT INFECTION |
46 |
0.0108 |
| 479 |
SMALL INTESTINAL OBSTRUCTION |
133 |
0.0108 |
| 480 |
LIVER ABSCESS |
35 |
0.0108 |
| 481 |
PERFORMANCE STATUS DECREASED |
50 |
0.0107 |
| 482 |
TRANSAMINASES INCREASED |
236 |
0.0106 |
| 483 |
HEPATIC CYST |
36 |
0.0106 |
| 484 |
APPENDICITIS |
99 |
0.0106 |
| 485 |
HYPONATRAEMIA |
596 |
0.0106 |
| 486 |
BRAIN OEDEMA |
133 |
0.0105 |
| 487 |
MYOCARDITIS |
120 |
0.0105 |
| 488 |
HYPOVOLAEMIA |
61 |
0.0104 |
| 489 |
NECROSIS |
58 |
0.0104 |
| 490 |
HEPATIC FUNCTION ABNORMAL |
387 |
0.0104 |
| 491 |
HYPERVOLAEMIA |
51 |
0.0103 |
| 492 |
LUNG ADENOCARCINOMA |
31 |
0.0103 |
| 493 |
TACHYPNOEA |
140 |
0.0103 |
| 494 |
COAGULOPATHY |
170 |
0.0102 |
| 495 |
HEARING IMPAIRED |
61 |
0.0102 |
| 496 |
INTERSTITIAL LUNG DISEASE |
488 |
0.0101 |
| 497 |
MYOPATHY |
86 |
0.0099 |
| 498 |
METASTASES TO BONE |
163 |
0.0099 |
| 499 |
NECROTISING FASCIITIS |
35 |
0.0099 |
| 500 |
ALANINE AMINOTRANSFERASE INCREASED |
609 |
0.0099 |
| 501 |
INFLAMMATORY MARKER INCREASED |
49 |
0.0099 |
| 502 |
PYREXIA |
3405 |
0.0098 |
| 503 |
PULMONARY FIBROSIS |
188 |
0.0098 |
| 504 |
LUNG INFECTION |
152 |
0.0098 |
| 505 |
CARDIAC FAILURE ACUTE |
65 |
0.0097 |
| 506 |
RENAL TUBULAR NECROSIS |
95 |
0.0097 |
| 507 |
DEAFNESS |
253 |
0.0097 |
| 508 |
OFF LABEL USE |
8393 |
0.0096 |
| 509 |
BLOOD ALBUMIN DECREASED |
76 |
0.0096 |
| 510 |
HAEMORRHAGE INTRACRANIAL |
140 |
0.0094 |
| 511 |
RENAL FAILURE ACUTE |
395 |
0.0093 |
| 512 |
SUPRAVENTRICULAR TACHYCARDIA |
89 |
0.0093 |
| 513 |
CEREBRAL ATROPHY |
37 |
0.0093 |
| 514 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
44 |
0.0093 |
| 515 |
URINE OUTPUT DECREASED |
81 |
0.0093 |
| 516 |
SUBARACHNOID HAEMORRHAGE |
94 |
0.0092 |
| 517 |
NON-SMALL CELL LUNG CANCER |
44 |
0.0092 |
| 518 |
SINUS TACHYCARDIA |
129 |
0.0091 |
| 519 |
VENTRICULAR ARRHYTHMIA |
33 |
0.0090 |
| 520 |
PYELONEPHRITIS |
78 |
0.0090 |
| 521 |
ORAL HERPES |
175 |
0.0090 |
| 522 |
ABSCESS LIMB |
38 |
0.0089 |
| 523 |
HEPATIC ENCEPHALOPATHY |
83 |
0.0089 |
| 524 |
MOUTH ULCERATION |
187 |
0.0089 |
| 525 |
ATAXIA |
105 |
0.0088 |
| 526 |
MULTIPLE MYELOMA |
41 |
0.0088 |
| 527 |
PARTIAL SEIZURES |
46 |
0.0088 |
| 528 |
OPTIC ISCHAEMIC NEUROPATHY |
34 |
0.0088 |
| 529 |
TRANSFUSION |
92 |
0.0088 |
| 530 |
NERVOUS SYSTEM DISORDER |
274 |
0.0088 |
| 531 |
ENDOCARDITIS |
45 |
0.0088 |
| 532 |
ARTHRITIS BACTERIAL |
36 |
0.0088 |
| 533 |
ACUTE KIDNEY INJURY |
1330 |
0.0087 |
| 534 |
LIPASE INCREASED |
66 |
0.0086 |
| 535 |
ORAL CANDIDIASIS |
113 |
0.0086 |
| 536 |
C-REACTIVE PROTEIN INCREASED |
311 |
0.0085 |
| 537 |
HEPATITIS CHOLESTATIC |
51 |
0.0085 |
| 538 |
UROSEPSIS |
78 |
0.0084 |
| 539 |
NO THERAPEUTIC RESPONSE |
103 |
0.0084 |
| 540 |
CONJUNCTIVAL HAEMORRHAGE |
32 |
0.0084 |
| 541 |
HEMIPARESIS |
141 |
0.0083 |
| 542 |
FAILURE TO THRIVE |
43 |
0.0083 |
| 543 |
INGUINAL HERNIA |
50 |
0.0082 |
| 544 |
SARCOIDOSIS |
39 |
0.0082 |
| 545 |
LOW BIRTH WEIGHT BABY |
65 |
0.0082 |
| 546 |
ASPARTATE AMINOTRANSFERASE INCREASED |
434 |
0.0082 |
| 547 |
RENAL IMPAIRMENT |
677 |
0.0080 |
| 548 |
GENERALISED OEDEMA |
99 |
0.0080 |
| 549 |
INTERVERTEBRAL DISC DISORDER |
34 |
0.0080 |
| 550 |
RESPIRATORY TRACT INFECTION |
207 |
0.0079 |
| 551 |
STATUS EPILEPTICUS |
89 |
0.0079 |
| 552 |
ATRIAL FIBRILLATION |
766 |
0.0079 |
| 553 |
ACIDOSIS |
60 |
0.0078 |
| 554 |
MENINGITIS |
52 |
0.0078 |
| 555 |
HYPERCALCAEMIA |
96 |
0.0078 |
| 556 |
PNEUMONIA |
2510 |
0.0077 |
| 557 |
CORONAVIRUS INFECTION |
51 |
0.0077 |
| 558 |
SKIN NECROSIS |
40 |
0.0077 |
| 559 |
CARDIAC FAILURE |
614 |
0.0076 |
| 560 |
BLOOD DISORDER |
61 |
0.0076 |
| 561 |
RENAL FAILURE |
1008 |
0.0076 |
| 562 |
RASH MACULO-PAPULAR |
167 |
0.0075 |
| 563 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
38 |
0.0075 |
| 564 |
INTESTINAL ISCHAEMIA |
41 |
0.0074 |
| 565 |
DEEP VEIN THROMBOSIS |
479 |
0.0074 |
| 566 |
ACUTE CORONARY SYNDROME |
61 |
0.0074 |
| 567 |
PROTHROMBIN TIME PROLONGED |
44 |
0.0073 |
| 568 |
CELLULITIS |
369 |
0.0073 |
| 569 |
PROCTALGIA |
47 |
0.0073 |
| 570 |
LEUKOCYTOSIS |
132 |
0.0073 |
| 571 |
HAEMOPTYSIS |
203 |
0.0073 |
| 572 |
HAEMOLYTIC ANAEMIA |
65 |
0.0072 |
| 573 |
HYPERGLYCAEMIA |
264 |
0.0072 |
| 574 |
ANURIA |
62 |
0.0072 |
| 575 |
CEREBRAL INFARCTION |
176 |
0.0072 |
| 576 |
TUBULOINTERSTITIAL NEPHRITIS |
135 |
0.0072 |
| 577 |
NEUROLOGICAL SYMPTOM |
41 |
0.0072 |
| 578 |
ATRIAL FLUTTER |
57 |
0.0071 |
| 579 |
HYPERTHYROIDISM |
102 |
0.0070 |
| 580 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
156 |
0.0070 |
| 581 |
MENTAL STATUS CHANGES |
195 |
0.0070 |
| 582 |
CEREBRAL HAEMORRHAGE |
250 |
0.0070 |
| 583 |
TOXIC SKIN ERUPTION |
70 |
0.0069 |
| 584 |
TOXICITY TO VARIOUS AGENTS |
1169 |
0.0069 |
| 585 |
RENAL CYST |
55 |
0.0069 |
| 586 |
TONSILLITIS |
36 |
0.0069 |
| 587 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
34 |
0.0068 |
| 588 |
PURPURA |
60 |
0.0068 |
| 589 |
OSTEONECROSIS |
222 |
0.0068 |
| 590 |
BLOOD CREATININE INCREASED |
438 |
0.0067 |
| 591 |
HEPATOCELLULAR INJURY |
95 |
0.0067 |
| 592 |
SHOCK |
153 |
0.0066 |
| 593 |
TACHYCARDIA |
582 |
0.0065 |
| 594 |
PULMONARY ARTERIAL HYPERTENSION |
94 |
0.0065 |
| 595 |
TREATMENT FAILURE |
536 |
0.0065 |
| 596 |
PROTEINURIA |
123 |
0.0065 |
| 597 |
PULMONARY OEDEMA |
289 |
0.0064 |
| 598 |
ANGIOPATHY |
36 |
0.0064 |
| 599 |
PULMONARY EMBOLISM |
610 |
0.0064 |
| 600 |
HEPATITIS |
163 |
0.0064 |
| 601 |
PATHOGEN RESISTANCE |
58 |
0.0064 |
| 602 |
HERPES ZOSTER |
365 |
0.0063 |
| 603 |
HICCUPS |
52 |
0.0063 |
| 604 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
157 |
0.0063 |
| 605 |
ACUTE MYOCARDIAL INFARCTION |
186 |
0.0063 |
| 606 |
ASPIRATION |
69 |
0.0063 |
| 607 |
PULMONARY HYPERTENSION |
131 |
0.0063 |
| 608 |
INTRACRANIAL PRESSURE INCREASED |
35 |
0.0063 |
| 609 |
HAEMOGLOBIN DECREASED |
641 |
0.0062 |
| 610 |
CEREBRAL ISCHAEMIA |
32 |
0.0062 |
| 611 |
SUBDURAL HAEMATOMA |
88 |
0.0061 |
| 612 |
BLOOD UREA INCREASED |
101 |
0.0060 |
| 613 |
HEMIPLEGIA |
50 |
0.0060 |
| 614 |
CHOLECYSTITIS ACUTE |
34 |
0.0060 |
| 615 |
NEPHROTIC SYNDROME |
41 |
0.0060 |
| 616 |
TYPE 1 DIABETES MELLITUS |
36 |
0.0060 |
| 617 |
CHOLANGITIS |
37 |
0.0060 |
| 618 |
NEUTROPHIL COUNT INCREASED |
61 |
0.0060 |
| 619 |
CHOLESTASIS |
114 |
0.0059 |
| 620 |
CIRCULATORY COLLAPSE |
101 |
0.0059 |
| 621 |
MITRAL VALVE INCOMPETENCE |
67 |
0.0059 |
| 622 |
LUNG DISORDER |
290 |
0.0059 |
| 623 |
LIVER DISORDER |
261 |
0.0059 |
| 624 |
RESPIRATORY DISORDER |
175 |
0.0058 |
| 625 |
HAEMATURIA |
199 |
0.0058 |
| 626 |
ANAL ABSCESS |
31 |
0.0057 |
| 627 |
MASS |
80 |
0.0057 |
| 628 |
FLUID OVERLOAD |
83 |
0.0057 |
| 629 |
HYPERVENTILATION |
33 |
0.0057 |
| 630 |
SINUS BRADYCARDIA |
55 |
0.0057 |
| 631 |
GENERAL PHYSICAL HEALTH DETERIORATION |
656 |
0.0057 |
| 632 |
FACIAL PARALYSIS |
48 |
0.0056 |
| 633 |
PLATELET COUNT INCREASED |
73 |
0.0056 |
| 634 |
BLOOD MAGNESIUM DECREASED |
48 |
0.0056 |
| 635 |
PETECHIAE |
58 |
0.0056 |
| 636 |
HYPERTHERMIA |
42 |
0.0055 |
| 637 |
HYPOTENSION |
1100 |
0.0055 |
| 638 |
PERICARDITIS |
92 |
0.0055 |
| 639 |
CENTRAL NERVOUS SYSTEM LESION |
75 |
0.0055 |
| 640 |
INTENTIONAL PRODUCT USE ISSUE |
478 |
0.0055 |
| 641 |
CHOLECYSTITIS |
65 |
0.0055 |
| 642 |
TOXIC EPIDERMAL NECROLYSIS |
82 |
0.0054 |
| 643 |
ABSCESS |
86 |
0.0054 |
| 644 |
HEPATITIS ACUTE |
35 |
0.0054 |
| 645 |
BLOOD URIC ACID INCREASED |
31 |
0.0054 |
| 646 |
HAEMORRHAGE |
561 |
0.0054 |
| 647 |
MYOCARDIAL ISCHAEMIA |
61 |
0.0054 |
| 648 |
PULMONARY MASS |
79 |
0.0053 |
| 649 |
LIVER INJURY |
129 |
0.0053 |
| 650 |
SUDDEN DEATH |
55 |
0.0052 |
| 651 |
GASTROINTESTINAL HAEMORRHAGE |
433 |
0.0052 |
| 652 |
SPINAL PAIN |
60 |
0.0051 |
| 653 |
INFUSION RELATED REACTION |
339 |
0.0051 |
| 654 |
DRUG-INDUCED LIVER INJURY |
160 |
0.0051 |
| 655 |
PRODUCT PRESCRIBING ISSUE |
111 |
0.0051 |
| 656 |
CARDIOGENIC SHOCK |
73 |
0.0051 |
| 657 |
PROCEDURAL COMPLICATION |
39 |
0.0051 |
| 658 |
HYPOPHAGIA |
130 |
0.0051 |
| 659 |
ORAL DISORDER |
37 |
0.0050 |
| 660 |
CYANOSIS |
79 |
0.0050 |
| 661 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
113 |
0.0048 |
| 662 |
SKIN INFECTION |
54 |
0.0048 |
| 663 |
GASTROINTESTINAL INFECTION |
43 |
0.0048 |
| 664 |
HAEMATOCRIT DECREASED |
95 |
0.0048 |
| 665 |
TRICUSPID VALVE INCOMPETENCE |
38 |
0.0048 |
| 666 |
DRUG ERUPTION |
84 |
0.0047 |
| 667 |
PULMONARY CONGESTION |
62 |
0.0047 |
| 668 |
DERMATITIS BULLOUS |
34 |
0.0047 |
| 669 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
79 |
0.0047 |
| 670 |
DYSPHAGIA |
439 |
0.0046 |
| 671 |
GASTROENTERITIS |
67 |
0.0046 |
| 672 |
ALTERED STATE OF CONSCIOUSNESS |
99 |
0.0046 |
| 673 |
VOMITING |
2144 |
0.0046 |
| 674 |
JAUNDICE |
122 |
0.0045 |
| 675 |
DEHYDRATION |
604 |
0.0045 |
| 676 |
APHASIA |
136 |
0.0045 |
| 677 |
VENTRICULAR FIBRILLATION |
50 |
0.0045 |
| 678 |
MOUTH HAEMORRHAGE |
33 |
0.0045 |
| 679 |
PANCREATITIS ACUTE |
101 |
0.0045 |
| 680 |
ANOREXIA |
57 |
0.0044 |
| 681 |
OXYGEN SATURATION DECREASED |
248 |
0.0044 |
| 682 |
BODY TEMPERATURE INCREASED |
90 |
0.0044 |
| 683 |
PREMATURE DELIVERY |
70 |
0.0044 |
| 684 |
RESPIRATORY RATE INCREASED |
39 |
0.0044 |
| 685 |
NEPHROPATHY |
41 |
0.0044 |
| 686 |
ISCHAEMIC STROKE |
78 |
0.0044 |
| 687 |
CARDIAC ARREST |
360 |
0.0044 |
| 688 |
GRAND MAL CONVULSION |
40 |
0.0043 |
| 689 |
ORAL PAIN |
96 |
0.0043 |
| 690 |
PREMATURE BABY |
129 |
0.0043 |
| 691 |
METABOLIC ACIDOSIS |
136 |
0.0042 |
| 692 |
DERMATITIS |
89 |
0.0042 |
| 693 |
ANAPHYLACTIC REACTION |
234 |
0.0042 |
| 694 |
GENERALISED TONIC-CLONIC SEIZURE |
70 |
0.0042 |
| 695 |
BRONCHOSPASM |
60 |
0.0042 |
| 696 |
BASAL CELL CARCINOMA |
65 |
0.0042 |
| 697 |
CARDIOMEGALY |
51 |
0.0041 |
| 698 |
CYSTITIS |
132 |
0.0041 |
| 699 |
EYELID PTOSIS |
42 |
0.0041 |
| 700 |
THERAPEUTIC RESPONSE DECREASED |
249 |
0.0041 |
| 701 |
IMMUNODEFICIENCY |
61 |
0.0041 |
| 702 |
HAEMATEMESIS |
103 |
0.0041 |
| 703 |
INFLAMMATION |
209 |
0.0040 |
| 704 |
SKIN LESION |
111 |
0.0040 |
| 705 |
BLOOD SODIUM DECREASED |
76 |
0.0040 |
| 706 |
DIARRHOEA HAEMORRHAGIC |
37 |
0.0040 |
| 707 |
MELAENA |
87 |
0.0039 |
| 708 |
HYPERKALAEMIA |
138 |
0.0039 |
| 709 |
TENDERNESS |
41 |
0.0039 |
| 710 |
MOTOR DYSFUNCTION |
40 |
0.0039 |
| 711 |
BONE PAIN |
229 |
0.0039 |
| 712 |
PHARYNGITIS |
48 |
0.0039 |
| 713 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
275 |
0.0039 |
| 714 |
HEPATIC STEATOSIS |
72 |
0.0039 |
| 715 |
PRODUCT USE ISSUE |
724 |
0.0038 |
| 716 |
ORTHOSTATIC HYPOTENSION |
67 |
0.0038 |
| 717 |
DISORIENTATION |
152 |
0.0038 |
| 718 |
AMENORRHOEA |
67 |
0.0038 |
| 719 |
CONVULSION |
218 |
0.0038 |
| 720 |
HYPOTONIA |
38 |
0.0038 |
| 721 |
WHITE BLOOD CELL COUNT INCREASED |
146 |
0.0038 |
| 722 |
EPISTAXIS |
283 |
0.0038 |
| 723 |
PERITONITIS |
78 |
0.0038 |
| 724 |
OEDEMA |
204 |
0.0038 |
| 725 |
DECREASED APPETITE |
867 |
0.0037 |
| 726 |
BRADYCARDIA |
197 |
0.0037 |
| 727 |
SEIZURE |
428 |
0.0037 |
| 728 |
ABDOMINAL PAIN |
859 |
0.0037 |
| 729 |
PNEUMONIA ASPIRATION |
92 |
0.0037 |
| 730 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
145 |
0.0037 |
| 731 |
THYROID CANCER |
44 |
0.0037 |
| 732 |
HAEMATOMA |
94 |
0.0036 |
| 733 |
NEURALGIA |
88 |
0.0036 |
| 734 |
DRUG INEFFECTIVE |
4758 |
0.0036 |
| 735 |
COMA |
171 |
0.0036 |
| 736 |
CARDIO-RESPIRATORY ARREST |
150 |
0.0036 |
| 737 |
PRODUCTIVE COUGH |
171 |
0.0036 |
| 738 |
EMPHYSEMA |
36 |
0.0036 |
| 739 |
SENSORY DISTURBANCE |
57 |
0.0035 |
| 740 |
DIARRHOEA |
2279 |
0.0035 |
| 741 |
DRUG INTOLERANCE |
341 |
0.0035 |
| 742 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
39 |
0.0035 |
| 743 |
RESPIRATORY DEPRESSION |
43 |
0.0035 |
| 744 |
EPILEPSY |
107 |
0.0035 |
| 745 |
IMMUNE SYSTEM DISORDER |
46 |
0.0035 |
| 746 |
NIGHT SWEATS |
112 |
0.0035 |
| 747 |
FULL BLOOD COUNT DECREASED |
70 |
0.0035 |
| 748 |
HEPATIC CYTOLYSIS |
44 |
0.0034 |
| 749 |
OROPHARYNGEAL DISCOMFORT |
31 |
0.0034 |
| 750 |
RED BLOOD CELL COUNT DECREASED |
98 |
0.0034 |
| 751 |
UNRESPONSIVE TO STIMULI |
88 |
0.0034 |
| 752 |
INCONTINENCE |
36 |
0.0034 |
| 753 |
DELIRIUM |
118 |
0.0034 |
| 754 |
GASTROINTESTINAL DISORDER |
303 |
0.0034 |
| 755 |
BLOOD CALCIUM DECREASED |
38 |
0.0034 |
| 756 |
DIPLOPIA |
87 |
0.0033 |
| 757 |
ERYTHEMA MULTIFORME |
31 |
0.0033 |
| 758 |
CHILLS |
389 |
0.0033 |
| 759 |
HYPOKINESIA |
48 |
0.0033 |
| 760 |
GASTRIC HAEMORRHAGE |
38 |
0.0033 |
| 761 |
CONSTIPATION |
720 |
0.0033 |
| 762 |
DEATH |
2838 |
0.0033 |
| 763 |
ARRHYTHMIA |
156 |
0.0033 |
| 764 |
COVID-19 |
576 |
0.0033 |
| 765 |
CONDITION AGGRAVATED |
992 |
0.0033 |
| 766 |
VASCULITIS |
38 |
0.0033 |
| 767 |
CONFUSIONAL STATE |
521 |
0.0032 |
| 768 |
ANAPHYLACTIC SHOCK |
83 |
0.0032 |
| 769 |
BLINDNESS |
131 |
0.0032 |
| 770 |
INTESTINAL OBSTRUCTION |
121 |
0.0032 |
| 771 |
SYNCOPE |
320 |
0.0032 |
| 772 |
DRUG INTERACTION |
505 |
0.0032 |
| 773 |
VENTRICULAR EXTRASYSTOLES |
33 |
0.0032 |
| 774 |
NAUSEA |
2495 |
0.0031 |
| 775 |
URINARY RETENTION |
105 |
0.0031 |
| 776 |
DYSPNOEA EXERTIONAL |
118 |
0.0031 |
| 777 |
TINNITUS |
143 |
0.0031 |
| 778 |
LIVER FUNCTION TEST ABNORMAL |
90 |
0.0031 |
| 779 |
MUSCULAR WEAKNESS |
351 |
0.0031 |
| 780 |
HYPOTHERMIA |
31 |
0.0031 |
| 781 |
BLOOD POTASSIUM DECREASED |
92 |
0.0031 |
| 782 |
OBSTRUCTIVE AIRWAYS DISORDER |
34 |
0.0031 |
| 783 |
ASTHENIA |
1142 |
0.0030 |
| 784 |
DIALYSIS |
43 |
0.0030 |
| 785 |
UPPER RESPIRATORY TRACT INFECTION |
140 |
0.0030 |
| 786 |
ILL-DEFINED DISORDER |
181 |
0.0030 |
| 787 |
PANCREATITIS |
155 |
0.0029 |
| 788 |
COGNITIVE DISORDER |
133 |
0.0028 |
| 789 |
VENTRICULAR TACHYCARDIA |
47 |
0.0028 |
| 790 |
FLUSHING |
289 |
0.0028 |
| 791 |
DRUG LEVEL INCREASED |
47 |
0.0028 |
| 792 |
HYPERTENSION |
601 |
0.0028 |
| 793 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
82 |
0.0028 |
| 794 |
DRUG EFFECT INCOMPLETE |
100 |
0.0028 |
| 795 |
DYSPNOEA |
1554 |
0.0027 |
| 796 |
LOWER RESPIRATORY TRACT INFECTION |
123 |
0.0027 |
| 797 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
46 |
0.0027 |
| 798 |
PARALYSIS |
38 |
0.0027 |
| 799 |
OBESITY |
42 |
0.0026 |
| 800 |
OSTEOMYELITIS |
47 |
0.0026 |
| 801 |
GASTRITIS |
68 |
0.0026 |
| 802 |
OEDEMA PERIPHERAL |
313 |
0.0026 |
| 803 |
RENAL DISORDER |
119 |
0.0026 |
| 804 |
SKIN ULCER |
66 |
0.0026 |
| 805 |
COUGH |
712 |
0.0025 |
| 806 |
MUSCLE SPASTICITY |
31 |
0.0025 |
| 807 |
HEPATIC ENZYME INCREASED |
170 |
0.0025 |
| 808 |
MATERNAL EXPOSURE DURING PREGNANCY |
222 |
0.0025 |
| 809 |
URINARY TRACT INFECTION |
423 |
0.0025 |
| 810 |
PSYCHOTIC DISORDER |
73 |
0.0025 |
| 811 |
DYSARTHRIA |
93 |
0.0025 |
| 812 |
DIVERTICULITIS |
68 |
0.0025 |
| 813 |
NEOPLASM MALIGNANT |
163 |
0.0024 |
| 814 |
THROMBOSIS |
195 |
0.0024 |
| 815 |
RECTAL HAEMORRHAGE |
104 |
0.0024 |
| 816 |
FEEDING DISORDER |
49 |
0.0024 |
| 817 |
PALLOR |
65 |
0.0024 |
| 818 |
PRESYNCOPE |
57 |
0.0023 |
| 819 |
FOETAL EXPOSURE DURING PREGNANCY |
189 |
0.0023 |
| 820 |
HYPOACUSIS |
100 |
0.0023 |
| 821 |
HAEMORRHOIDS |
45 |
0.0023 |
| 822 |
COORDINATION ABNORMAL |
32 |
0.0023 |
| 823 |
SKIN DISORDER |
76 |
0.0023 |
| 824 |
ALOPECIA |
446 |
0.0023 |
| 825 |
ABDOMINAL PAIN LOWER |
57 |
0.0023 |
| 826 |
STEVENS-JOHNSON SYNDROME |
50 |
0.0022 |
| 827 |
LETHARGY |
128 |
0.0022 |
| 828 |
CHEST DISCOMFORT |
227 |
0.0022 |
| 829 |
RESPIRATORY ARREST |
61 |
0.0022 |
| 830 |
MUSCULOSKELETAL CHEST PAIN |
34 |
0.0022 |
| 831 |
FACE OEDEMA |
37 |
0.0022 |
| 832 |
GASTRIC ULCER |
41 |
0.0022 |
| 833 |
RASH ERYTHEMATOUS |
103 |
0.0022 |
| 834 |
DYSURIA |
79 |
0.0021 |
| 835 |
RHABDOMYOLYSIS |
89 |
0.0021 |
| 836 |
CHEST PAIN |
395 |
0.0021 |
| 837 |
LIVER FUNCTION TEST INCREASED |
45 |
0.0021 |
| 838 |
OROPHARYNGEAL PAIN |
194 |
0.0021 |
| 839 |
BLOOD POTASSIUM INCREASED |
34 |
0.0021 |
| 840 |
URINARY INCONTINENCE |
62 |
0.0021 |
| 841 |
INTERNATIONAL NORMALISED RATIO INCREASED |
59 |
0.0021 |
| 842 |
CARDIAC FAILURE CONGESTIVE |
166 |
0.0021 |
| 843 |
BLOOD TRIGLYCERIDES INCREASED |
36 |
0.0020 |
| 844 |
EATING DISORDER |
43 |
0.0020 |
| 845 |
ERYTHEMA |
411 |
0.0020 |
| 846 |
CONJUNCTIVITIS |
37 |
0.0020 |
| 847 |
PELVIC PAIN |
36 |
0.0020 |
| 848 |
ELECTROCARDIOGRAM QT PROLONGED |
71 |
0.0020 |
| 849 |
SLEEP APNOEA SYNDROME |
37 |
0.0019 |
| 850 |
WEIGHT DECREASED |
540 |
0.0019 |
| 851 |
BLOOD PRESSURE DECREASED |
128 |
0.0019 |
| 852 |
FATIGUE |
1497 |
0.0019 |
| 853 |
DIABETIC KETOACIDOSIS |
46 |
0.0019 |
| 854 |
ANGINA PECTORIS |
54 |
0.0019 |
| 855 |
LUNG NEOPLASM MALIGNANT |
77 |
0.0019 |
| 856 |
BACK PAIN |
434 |
0.0019 |
| 857 |
POST PROCEDURAL COMPLICATION |
35 |
0.0018 |
| 858 |
MUSCULOSKELETAL PAIN |
95 |
0.0018 |
| 859 |
CARDIOVASCULAR DISORDER |
46 |
0.0018 |
| 860 |
LACTIC ACIDOSIS |
58 |
0.0018 |
| 861 |
SPEECH DISORDER |
93 |
0.0018 |
| 862 |
SINUSITIS |
181 |
0.0018 |
| 863 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
50 |
0.0017 |
| 864 |
HYPOAESTHESIA |
257 |
0.0017 |
| 865 |
ABDOMINAL DISTENSION |
179 |
0.0017 |
| 866 |
TOOTH DISORDER |
38 |
0.0017 |
| 867 |
PARAESTHESIA |
268 |
0.0017 |
| 868 |
BONE DISORDER |
31 |
0.0017 |
| 869 |
LOSS OF CONSCIOUSNESS |
217 |
0.0017 |
| 870 |
EXPOSURE DURING PREGNANCY |
105 |
0.0017 |
| 871 |
LABORATORY TEST ABNORMAL |
49 |
0.0017 |
| 872 |
RENAL INJURY |
49 |
0.0016 |
| 873 |
HYPOGLYCAEMIA |
79 |
0.0016 |
| 874 |
RHINORRHOEA |
105 |
0.0016 |
| 875 |
EAR PAIN |
31 |
0.0016 |
| 876 |
RASH |
693 |
0.0016 |
| 877 |
PAIN IN JAW |
44 |
0.0016 |
| 878 |
AGITATION |
114 |
0.0016 |
| 879 |
TRANSIENT ISCHAEMIC ATTACK |
52 |
0.0015 |
| 880 |
INFLUENZA |
170 |
0.0015 |
| 881 |
CHRONIC KIDNEY DISEASE |
113 |
0.0015 |
| 882 |
THROAT TIGHTNESS |
40 |
0.0015 |
| 883 |
CARDIAC DISORDER |
138 |
0.0015 |
| 884 |
GASTRIC CANCER |
37 |
0.0015 |
| 885 |
DISTURBANCE IN ATTENTION |
78 |
0.0014 |
| 886 |
RESTLESSNESS |
51 |
0.0014 |
| 887 |
LIP SWELLING |
46 |
0.0014 |
| 888 |
HYPERSENSITIVITY |
255 |
0.0014 |
| 889 |
CHOLELITHIASIS |
45 |
0.0014 |
| 890 |
DYSPHONIA |
76 |
0.0013 |
| 891 |
HEART RATE INCREASED |
126 |
0.0013 |
| 892 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
66 |
0.0013 |
| 893 |
CONTRAINDICATED PRODUCT ADMINISTERED |
38 |
0.0013 |
| 894 |
VAGINAL HAEMORRHAGE |
54 |
0.0012 |
| 895 |
MYALGIA |
210 |
0.0012 |
| 896 |
HAEMATOCHEZIA |
68 |
0.0012 |
| 897 |
PAIN IN EXTREMITY |
363 |
0.0012 |
| 898 |
HYPERHIDROSIS |
157 |
0.0012 |
| 899 |
HEADACHE |
762 |
0.0012 |
| 900 |
MYOCARDIAL INFARCTION |
212 |
0.0012 |
| 901 |
DYSGEUSIA |
90 |
0.0012 |
| 902 |
DYSPEPSIA |
119 |
0.0012 |
| 903 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
31 |
0.0012 |
| 904 |
VISUAL ACUITY REDUCED |
40 |
0.0012 |
| 905 |
RASH PRURITIC |
64 |
0.0012 |
| 906 |
SOMNOLENCE |
237 |
0.0012 |
| 907 |
TYPE 2 DIABETES MELLITUS |
39 |
0.0012 |
| 908 |
MOBILITY DECREASED |
82 |
0.0011 |
| 909 |
WHEEZING |
67 |
0.0011 |
| 910 |
NECK PAIN |
63 |
0.0011 |
| 911 |
CEREBROVASCULAR ACCIDENT |
190 |
0.0011 |
| 912 |
BRONCHITIS |
82 |
0.0011 |
| 913 |
ADVERSE EVENT |
102 |
0.0011 |
| 914 |
DIZZINESS |
552 |
0.0011 |
| 915 |
BLISTER |
62 |
0.0011 |
| 916 |
SWELLING FACE |
71 |
0.0011 |
| 917 |
MOVEMENT DISORDER |
35 |
0.0011 |
| 918 |
CATARACT |
64 |
0.0011 |
| 919 |
FEMUR FRACTURE |
33 |
0.0011 |
| 920 |
POLLAKIURIA |
44 |
0.0011 |
| 921 |
BALANCE DISORDER |
91 |
0.0011 |
| 922 |
ABDOMINAL PAIN UPPER |
216 |
0.0010 |
| 923 |
HALLUCINATION |
79 |
0.0010 |
| 924 |
OSTEOPOROSIS |
42 |
0.0010 |
| 925 |
ANGIOEDEMA |
45 |
0.0010 |
| 926 |
TREMOR |
168 |
0.0010 |
| 927 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
45 |
0.0010 |
| 928 |
GAIT DISTURBANCE |
192 |
0.0010 |
| 929 |
NO ADVERSE EVENT |
178 |
0.0010 |
| 930 |
IMPAIRED HEALING |
32 |
0.0010 |
| 931 |
PAIN |
590 |
0.0010 |
| 932 |
VERTIGO |
57 |
0.0009 |
| 933 |
DIABETES MELLITUS |
71 |
0.0009 |
| 934 |
VISUAL IMPAIRMENT |
115 |
0.0009 |
| 935 |
FLUID RETENTION |
47 |
0.0009 |
| 936 |
TREATMENT NONCOMPLIANCE |
50 |
0.0009 |
| 937 |
SKIN EXFOLIATION |
77 |
0.0009 |
| 938 |
UNEVALUABLE EVENT |
66 |
0.0009 |
| 939 |
FALL |
289 |
0.0009 |
| 940 |
MALAISE |
375 |
0.0009 |
| 941 |
MENTAL DISORDER |
37 |
0.0008 |
| 942 |
SWELLING |
77 |
0.0008 |
| 943 |
PALPITATIONS |
96 |
0.0008 |
| 944 |
ARTHRALGIA |
340 |
0.0008 |
| 945 |
FEELING HOT |
50 |
0.0008 |
| 946 |
DEPRESSION |
185 |
0.0008 |
| 947 |
PRURITUS |
303 |
0.0008 |
| 948 |
DYSKINESIA |
32 |
0.0008 |
| 949 |
MEDICATION ERROR |
41 |
0.0007 |
| 950 |
SKIN DISCOLOURATION |
33 |
0.0007 |
| 951 |
BLOOD PRESSURE INCREASED |
109 |
0.0007 |
| 952 |
WEIGHT INCREASED |
159 |
0.0007 |
| 953 |
SLEEP DISORDER |
50 |
0.0007 |
| 954 |
OCULAR HYPERAEMIA |
32 |
0.0007 |
| 955 |
IRRITABILITY |
40 |
0.0007 |
| 956 |
DISCOMFORT |
40 |
0.0007 |
| 957 |
VISION BLURRED |
89 |
0.0006 |
| 958 |
DRY MOUTH |
52 |
0.0006 |
| 959 |
GASTROOESOPHAGEAL REFLUX DISEASE |
50 |
0.0006 |
| 960 |
MEMORY IMPAIRMENT |
83 |
0.0006 |
| 961 |
PROSTATE CANCER |
48 |
0.0006 |
| 962 |
MUSCLE SPASMS |
109 |
0.0006 |
| 963 |
ABDOMINAL DISCOMFORT |
96 |
0.0006 |
| 964 |
AMNESIA |
37 |
0.0006 |
| 965 |
EYE PAIN |
31 |
0.0005 |
| 966 |
CONTUSION |
50 |
0.0005 |
| 967 |
DEVICE MALFUNCTION |
36 |
0.0005 |
| 968 |
INJECTION SITE REACTION |
35 |
0.0005 |
| 969 |
ARTHRITIS |
40 |
0.0005 |
| 970 |
ANXIETY |
139 |
0.0005 |
| 971 |
HOSPITALISATION |
73 |
0.0005 |
| 972 |
URTICARIA |
79 |
0.0005 |
| 973 |
INSOMNIA |
123 |
0.0005 |
| 974 |
ADVERSE DRUG REACTION |
41 |
0.0005 |
| 975 |
DRUG ABUSE |
38 |
0.0005 |
| 976 |
PERIPHERAL SWELLING |
70 |
0.0005 |
| 977 |
BLOOD GLUCOSE INCREASED |
84 |
0.0004 |
| 978 |
HOT FLUSH |
33 |
0.0004 |
| 979 |
DRY SKIN |
55 |
0.0004 |
| 980 |
BREAST CANCER |
35 |
0.0004 |
| 981 |
EMOTIONAL DISTRESS |
41 |
0.0003 |
| 982 |
MIGRAINE |
32 |
0.0003 |
| 983 |
OVERDOSE |
69 |
0.0003 |
| 984 |
FEELING ABNORMAL |
72 |
0.0003 |
| 985 |
PSORIASIS |
36 |
0.0003 |
| 986 |
NASOPHARYNGITIS |
50 |
0.0003 |
| 987 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
31 |
0.0002 |